Blepharoplasty Market Forecasts to 2030 - Global Analysis By Type (Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty and Combination Eyelid Surgery), Gender, Service Provider and By Geography

According to Stratistics MRC, the Global Blepharoplasty Market is accounted for $4.08 billion in 2023 and is expected to reach $7.75 billion by 2030 growing at a CAGR of 9.6% during the forecast period. A surgical technique called blepharoplasty aims to improve the appearance of the eyelids, specifically the upper, lower, or both. This cosmetic procedure can produce a more young and refreshed appearance and is frequently used to address numerous issues connected to the aging of the eyelids. In order to address aging symptoms such sagging or extra skin, wrinkles, and puffiness around the eyes, blepharoplasty is frequently performed. In addition to its cosmetic advantages, blepharoplasty can help with practical problems including visual impairment brought on by sagging upper eyelids. Some people get blepharoplasty to make their face look better overall and look more youthful.

According to a study conducted by the British Association of Aesthetic Plastic Surgeons, requests for virtual consultations for surgical procedures jumped by 70% during the lockdown in preparation for in-person treatment following the lockdown.

Market Dynamics:

Driver:

Increasing demand for the surgery among the aged population

The aging of the population, rising disposable money, and the desire to improve one's look are all contributing causes to the growth. Furthermore, the treatment is becoming more and more popular outside of the United States as well, including in China, Japan, and South Korea. The development of novel treatments, including non-invasive procedures and cutting-edge technologies, as a result of the increasing demand for blepharoplasty has also helped the industry expand. The aging population's desire to maintain a youthful appearance is a major market driver for blepharoplasty, and this trend is anticipated to persist in the years to come, supporting market expansion.

Restraint:

High cost

Depending on the degree of the procedure, as well as other elements including the surgeon's competence and location, the typical cost of blepharoplasty surgery in the United States varies. Some prospective patients are discouraged from having the surgery because of its exorbitant cost, especially those who lack sufficient health insurance or disposable income. Additionally, there is a chance that the surgery can have side effects like infection, bleeding, and scarring, which discourages patients from having the treatment done which hamper the growth of the market

Opportunity:

Customization utilizing new surgical methods

Blepharoplasty has become safer and more efficient thanks to improvements in surgical methods and technology. The operation is becoming more and more popular, in part because of minimally invasive techniques, quick recoveries, and better results. Procedures for blepharoplasty can be customized to each patient's unique requirements and objectives. In order to treat specific symptoms, such as upper eyelid sagging, lower eyelid puffiness, or a combination of problems, surgeons might tailor the procedure. Additionally, the market is expanding as a result of technological developments such plasma technology and laser-assisted devices, which offer precise and controlled tissue ablation and tightening with little harm to neighbouring tissues.

Threat:

Safety concerns with health insurance coverage

High-profile blepharoplasty-related problems or adverse events can damage public confidence and turn away potential patients. There may be more oversight and regulations as a result of safety concerns. For certain patients, access to blepharoplasty procedures may be hampered by limited or non-existent insurance coverage. Potential patients may be discouraged by the procedure's out-of-pocket cost, especially those who are on a limited budget. The market may be impacted by modifications to laws governing cosmetic surgery, especially blepharoplasty. Stricter rules or licensing requirements may raise the cost of practicing and reduce the availability of practitioners, which may have an impact on how accessible the treatment and the market.

COVID-19 Impact

The COVID-19 outbreak has hampered operations in the global healthcare industry. Blepharoplasty surgery has been significantly impacted by the COVID-19 pandemic. Strict lockdowns and social segregation policies have been put in place by several nations around the world, which have disrupted access to healthcare services and lowered the number of patients choosing to have blepharoplasty.

The upper eyelid blepharoplasty segment is expected to be the largest during the forecast period

The upper eyelid blepharoplasty segment is estimated to have a lucrative growth, as it is a type of cosmetic surgery that aims to improve the appearance of the upper eyelids. This surgery is frequently used to treat a variety of aesthetic issues brought on by aging, heredity, or other factors. By addressing concerns like extra skin and wrinkles on the top eyelids, hooded or drooping upper eyelids that may impair vision, and puffy or bulging fat deposits in the upper eyelid area, upper eyelid blepharoplasty aims to produce a more youthful and rejuvenated appearance thus driving the growth of the blepharoplasty market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rise in patients having cosmetic surgery performed at hospitals as well as the increase in hospitals offering surgical procedures for the eyelid using cutting-edge medical technology. The postoperative treatment and instructions are given by hospital staff and may include recommendations for managing pain, caring for open wounds, and lowering swelling and bruising. Once a patient is stable and awake, they are typically released detailed postoperative instructions, including information on eye care, drugs, and activities to avoid during the early recovery phase, are frequently given to patients by hospital staff and surgeons.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of pharmaceutical and medical device manufacturers in the area, as well as the increase in the geriatric population in nations like China and India, are both responsible for the market growth in this area. an increase in the number of elderly people, a rise in the number of people who have saggy or droopy upper eyelids as a result of sedentary lifestyles, and an increase in screen time as a result of the COVID-19 epidemic. Additionally, it is anticipated that the market for blepharoplasty would experience rise throughout the projection period because to the growing inclination for minimally invasive procedures. Double eyelid surgery is the most popular procedure in several Asian nations, particularly in Korea enhances the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the existence of several significant key players and the rapid technological advancement of medical devices in this area. The main driver of the market's expansion is the rise in the number of people having blepharoplasty treatments to enhance the appearance of their eyes using innovative and sophisticated cosmetic techniques including laser resurfacing and dermal fillers. For instance, a report from the International Society of Aesthetic Plastic Surgery from 2021 estimates that 149,668 eyelid surgery treatments were completed there, compared to 53,253 in the U.S. which are propelling the growth of the regions market.

Key players in the market:

Some of the key players profiled in the Blepharoplasty Market include: Abbvie Inc, Allergan, Alma Lasers, Cynosure, Erchonia Corporation, Galderma, Grand Aespio Inc., Hologic, Johnson & Johnson, LightScalpel, London Bridge Plastic Surgery, Lumenis, M A Corporation, Medline industries, inc., Medtronic plc, Merz Pharma, Sientra, Sisram Medical Ltd, Surgical Holdings Ltd, Valeant Pharmaceuticals International and Zimmer Biomet.

Key Developments:

In October 2023, Allergan Aesthetics and Girls Inc. partner to speed the entry of young Women into Positions of Leadership in the STEM Field. The Allergan Aesthetics effort will focus specifically on leadership paths in STEM (science, technology, engineering, and math).

In October 2023, Johnson & Johnson Company announced a development and commercialization agreement with Sanofi for Janssen's extraintestinal pathogenic Escherichia coli (ExPEC) investigational vaccine program. The lead vaccine candidate is currently being evaluated in the Phase 3 E.mbrace study for the prevention of invasive E. coli disease (IED) in adults aged 60 years and older.

In July 2023, AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.

Types Covered:

• Upper Eyelid Blepharoplasty
• Lower Eyelid Blepharoplasty
• Combination Eyelid Surgery

Genders Covered:

• Female
• Male

Service Providers Covered:

• Hospitals
• Clinics
• Ambulatory Surgical Centre

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances